Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Pabst, Thomas" or (type exact bookEditor and editor="Pabst, Thomas") Add to list Journal Article A1 open access Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with AML and high risk MDS Jeroen Janssen, Bob Lowenberg, Markus Manz, Mario Bargetzi, Bart Biemond, Peter von Dem Borne, Dimitri Breems, Rolf Brouwer, Yves Chalandon, Dries Deeren, et al. (2021) CANCERS. 13(4). Add to list Journal Article A1 open access Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial Bob Lowenberg, Thomas Pabst, Johan Maertens, Patrycja Gradowska, Bart J. Biemond, Olivier Spertini, Edo Vellenga, Laimonas Griskevicius, Lidwine W. Tick, Mojca Jongen-Lavrencic, et al. (2021) BLOOD ADVANCES. 5(4). p.1110-1121 Add to list Journal Article A1 open access Molecular and translational classifications of DAMPs in immunogenic cell death Abhishek D Garg, Lorenzo Galluzzi, Lionel Apetoh, Thais Baert, Raymond B Birge, José Manuel Bravo-San Pedro, Karine Breckpot, David Brough, Ricardo Chaurio, Mara Cirone, et al. (2015) FRONTIERS IN IMMUNOLOGY. 6.